Loading...

SONM DNA X INC Company Mergers 8-K Filing

DN X

SNM

DNA X INC

(SONM)

2025 8-K

Funding Agreement

Financial Results Announced

Accountant Change

Financial Results Announced

Acquisition Reporting

CEO Appointment

Management Changes

Asset Sale Completion

Asset Sale Approved

Corporate Investment Update

Retention Bonus Approved

Asset Purchase Update

Nasdaq Compliance Regained

Financial Results Announced

Stock Split Approved

Equity Facility Agreement

Nasdaq Listing Deficiency

Delisting Notice

Compensatory Arrangements o...

Asset Acquisitions

Debt Restructuring

Equity Offerings

Merger of Equals

Equity Offerings

Financial Statements

Stockholder Rights Agreement

CFO Agreement Update

CEO Agreement Update

Financial Results

Note Purchase Agreement

Employee Incentives

Strategic Review

Financial Results

Financial Results

Receivables Financing

Earnings Reports

Sales Agreement

Compliance with Nasdaq List...

Reverse Stock Split

Reverse Stock Split

Annual Meeting Approval

Amendments to Bylaws

Amendment to Registration R...

Amendment to 2024 Annual Me...

Earnings Reports

Private Placement

Financial Results Announcement

Employment Agreements

Financial Results Announcement

Earnings Release

Retirement of Directors

Correction of Press Release

Financial Results Announcement

SEC Investigation Conclusion

External Links:

On December 15, 2025, Sonim Technologies Inc. issued a $1.2 million convertible promissory note to DNA Holdings and acquired 100% of DNA X LLC for 223,201 shares of its common stock. This deal aligns Sonim with advanced trading technology and includes a provision for potential share conversion and voting arrangements.

AI Assistant

DNA X INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.